Georgios Tsormpas

2002 – 2003                      Aventis Expedition Study, a double blinded, placebo controlled multinational trial to investigate the effect of IV treatment with the Na+/H+ exhange inhibitor CARIPORIDE (HOE642) on all-cause mortality and non-fatal myocardial infarction in patients at risk for myocardial necrosis during and after coronary artery bypass graft (CABG) surgery (HOE642A/3002). Aventis Pharmaceuticals, Inc. [Cardiac Thoracic Surgery Clinic, “Georgios Papanikolaou” Hospital of Thessaloniki, Greece, Center Sub Investigator]

2016 Minimally Invasive Mitral Repair , Munich Cardiothoracic Center, Germany 2010- Master of Valve (Mitral) course, Monaco, Prof. Gilles Dreyfus. 1999-2003 Cardiothoracic Residency, G. Papanikolaou Hosp. 1996-1999 General Surgery Residency, AHEPA Gen. University Hosp. 1986-1992 Medical School, Aristotelian University of Thessaloniki, Greece.